For the study, published in JAMA Network Open, researchers searched the Medline/PubMed and Embase databases as well as preprint servers bioRxiv and medRxiv for COVID-19 studies conducted from Nov. 1, 2019, to March 30. Studies published on preprint servers typically have not been peer-reviewed.
Researchers identified and analyzed 29 studies, mostly from China, involving 4,805 patients with COVID-19.
They found that 7.4 percent of patients reported having diarrhea and 4.6 percent reported being nauseous or vomiting.
Viral genetic material was detected in the feces of 40.5 percent of patients with COVID-19.
More articles on infection control:
New Mexico hospital’s COVID-19 screening unfair to Native American women, clinicians say
FEMA plans to have providers reuse masks, gowns
Nurse union balks at reuse of stained, decontaminated N95 masks
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.